Navigation Links
Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months

- Worldwide Net Revenue Increased 4% for the 2008 Third Quarter and

5% for the 2008 First Nine Months

- Third Quarter Revenue Growth in Pharmaceuticals Division Led by

Solid Growth of Enbrel +32%, Nutritionals +18% and Prevnar +13%

- Guidance for 2008 Full Year Diluted EPS, before Certain Significant

Items, Revised to a Range of $3.49 to $3.55

- Dividend to Stockholders Increased by 7.1%

MADISON, N.J., Oct. 22 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) today reported results for the 2008 third quarter and first nine months ending September 30, 2008. Worldwide net revenue increased 4%, to $5.8 billion, for the 2008 third quarter and 5%, to $17.5 billion, for the first nine months of 2008. Excluding the favorable impact of foreign exchange, worldwide net revenue increased 2% for the 2008 third quarter and increased 1% for the 2008 first nine months.

"Wyeth's results so far this year reflect the continued solid performance of our major growth engines - Enbrel, Prevnar and our Nutritionals franchise," said Bernard Poussot, Chairman, President and Chief Executive Officer. "For the first nine months of 2008, our revenues grew five percent despite the launch of Protonix generics last December. Wyeth has become a well diversified global biopharmaceutical company with 43 percent of its revenues represented by vaccines, biotechnology and nutritional products."

Product Highlights for the Third Quarter and First Nine Months of 2008

The following table presents worldwide net revenue from Wyeth's principal products for the 2008 third quarter and first nine months, together with the percentage changes from the comparable periods in th

Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Wyeth Wins Philadelphia Diet Drug Trial Involving Claim of PPH
2. Wyeth Announces Increase in Common Stock Dividend
3. Retrospective Analysis of Phase 3 Data Suggest Wyeths Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
4. Wyeth Sets Webcast And Conference Call for 2008 Third Quarter Earnings
5. Cyprus and Ireland Add Wyeths 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules
6. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
7. Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
8. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
9. Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
10. Wyeth Declares Common and Preferred Stock Dividends
11. Wyeth Pharmaceuticals Announces Organizational Change
Post Your Comments:
(Date:1/22/2015)... / Rootstown, OH (PRWEB) January 22, 2015 ... platform, announced today that it has received AOAC-PTM Certifications for ... O1O3, O111, O121, and O145; collectively referred to as STEC ... O157, at 1 colony forming unit (cfu) per 325 g ...
(Date:1/22/2015)... WI (PRWEB) January 22, 2015 Dr. Greg ... the 12th annual Scripps Natural Supplements Pre-Conference seminar on probiotics ... Conference is an annual continuing education conference for health care ... and included the topic of probiotics in health. Dr. Leyer ...
(Date:1/22/2015)... January 22, 2015 Diagenode, Inc., ... as the Bioruptor® and complete solutions for epigenetics ... chromatin immunoprecipitation, alleviating the need for manual processing. ... needed for ChIP of histones or transcription factors ...
(Date:1/22/2015)... Medical Systems (NYSE: VAR ), world leader in ... to sustainability with inclusion on a prestigious list of the ... equipment company among the Corporate Knights Global 100 Most Sustainable ... Davos, Switzerland . "We ...
Breaking Biology Technology:Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Varian Honored Among World's 100 Most Sustainable Corporations 2
... What and When, Additional results from the ... pioGlitazOne) published,today in Circulation revealed that reduced progression ... was,associated with increased levels of HDL cholesterol (HDL-C, ... increased effect on HDL-C levels at 24 weeks ...
... April 15 Pacira Pharmaceuticals, Inc. today,announced ... the,development of sustained release injectable products based ... companies will work,together to enhance the dosing ... development pipeline. The goal of the collaboration ...
... Inc.,(Nasdaq: BNVI ) will present findings on the ... and BN108 at the American Association of,Cancer Research (AACR) ... San,Diego, CA, April 12 - 16, 2008., Bionovo,s ... (cell death) induced by BN107 and BN108. As explained ...
Cached Biology Technology:New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with ACTOS(R) (pioglitazone HCl) 2New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with ACTOS(R) (pioglitazone HCl) 3Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R) 2Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research 2
(Date:1/22/2015)... Inc. (NASDAQ: NXTD and NXTDW) a biometric authentication company ... of the Wocket™ smart wallet at CES 2015 in Las ... one of the "11 Hot Products at CES" in a review published ... Far" by and "The top 10 gadgets from CES 2015" by ...
(Date:1/22/2015)... EyeLock, Inc. , a market leader of iris-based identity authentication ... to the new role of Senior Vice President of Mobile ... mobile platforms and wearable solutions for EyeLock,s technologies. Gerber brings ... semiconductor industry to his role at EyeLock, with expertise in ...
(Date:12/22/2014)... 2014 Holiday Season may be the brightest ever for ... the long anticipated floodgates for consumer biometrics may finally ... phones, tablets, and wearable mobile devices that incorporate biometrics ... with nearly 4.8 billion biometric devices by 2020.   ...
Breaking Biology News(10 mins):CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2
... do some microorganisms manage to exist and even thrive ... A team of scientists from the Weizmann Institute's Plant ... that a switch in just two amino acids (the ... functioning best at moderate temperatures and being adapted to ...
... 20 and older has risen from about 5.1 percent to ... Health (NIH) and the Centers for Disease Control and Prevention ... 1994 and 1999 to 2002. However, the percentage of ... years studied. About 2.8 percent of U.S. adult--one-third of ...
... Lauren Gerson, MD, so overjoyed are they at hearing her ... eat chocolate. Indulge your passion for spicy cuisine. Drink red ... juice with breakfast and, what the heck, eat a grapefruit, ... evidence to support the notion that eating these foods will ...
Cached Biology News:Bacteria beat the heat 2One-third of adults with diabetes still don't know they have it 2One-third of adults with diabetes still don't know they have it 3One-third of adults with diabetes still don't know they have it 4Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 2Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 3Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 4
sTNF-receptor I Polyclonal Antibody 100 ug affinity purified rabbit anti-human sTNF-receptor I polyclonal antibody. Performs well in WB/Elisa/Neutralization....
... perfusion system for small volumes of ... or general liquid-handling research applications. ... microliters of precious drugs. Switch between ... from a single tip. Minimize ...
Biology Products: